Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

Association of Growth Factors Genes with Miscarriage

Authors
Tatiana Marakhovskaya
Elena Butenko
Konstantin Kovalenko
Elena Mashkina
Department of Genetics, Southern Federal University, Rostov-on-Don, Russia
Abstract
Background: The study was aimed to investigate the association of VEGFA gene polymorphic variants -2578C>A (rs699947) and -634G>C (rs2010963) and TGFB1 gene 915G>C (rs1800471) and gene expression level with miscarriage in the first trimester. Methods: 288 women with different courses of pregnancy and 61 chorionic tissue samples were involved in case-control study. Allele-specific polymerase chain reaction in real time was used for genotyping. Next, gene-gene interactions were analyzed using the multifactor dimensionality reduction method. VEGFA and TGFВ1 genes expression levels were determined by RT-PCR. Results: It was found that SNP rs699947 was associated with the miscarriage risk change (p=0.05). The CC genotype was associated with reduced risk of abortion in the first trimester, and the CA genotype with increased risk. Genotypes VEGFA -2578CС/VEGFА -634CG, VEGFA -2578AА/VEGFА -634CG, and VEGFA -2578CС/VEGFА -634CG/TGFВ1 936CC were associated with lowered risk of miscarriage in the first trimester. mRNA level of TGFВ1 was significantly higher in decidual tissue compared to chorionic tissue in normally progressing pregnancy (p=0.003). VEGFA gene expression level was directly correlated with the TGFВ1 mRNA level (R=0.60; р=0.038). In pregnancy loss, an inverse relationship was observed (R=-0.76; р=0.028). Conclusion: The SNP rs699947 is associated with pregnancy loss in the first trimester. The MDR analysis data showed the significant relationship between VEGFA and TGFB1 genes in two-locus and three-locus models. A change in the ratio of the concentrations of growth factors can disrupt the processes of cell division, apoptosis and angiogenesis processes.
Keywords
Chorionic tissue
Decidua
Gene expression
Gene polymorphic variants
Growth Factors
Miscarriage
Graham СН, Lysiak JJ, McCrae KR, Lala PK. Localization of transforming growth factor-beta at the human fetal-maternal interface: role in trophoblast growth and differentiation. Biol Reprod 1992;46(4):561-72.
Singh M, Orazulike NC, Ashmore J, Konje JC. Changes in maternal serum transforming growth factor beta-1 during pregnancy: a cross-sectional study. Biomed Res Int. 2013;2013:318464.
Wen Z, Shen Y, Berry G, Shahram F, Li Y, Watanabe R, et al. The microvascular niche instructs T cells in large vessel vasculitis via the VEGF-Jagged1-Notch pathway. Sci Transl Med. 2017;9(399). pii: eaal3322.
Wang Y, Liu Y, Fan Z, Liu D, Wang F, Zhou Y. IGFBP2 enhances adipogenic differentiation potentials of mesenchymal stem cells from Wharton's jelly of the umbilical cord via JNK and Akt signaling pathways. PLoS One. 2017;12(8):e0184182.
Mattei MG, Borg JP, Rosnet O, Marme D, Birnbaum D. Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) genes to human chromosome 6p12-p21 and 14q24-q31 regions, respectively. Genomics. 1996;32(1):168-9.
Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, Sudhakar A, et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induced proteinuria. J Biol Chem. 2003;278(15):12605-8.
Paleolog EM. Angiogenesis in rheumatoid arthritis. Arthritis Res Ther. 2002;4(3):81-90.
Yoo J, Ghiassi M, Jirmanova L, Balliet AG, Hoffman B, Fornace AJ Jr, et al. Transforming growth factor-beta-induced apoptosis is mediated by Smad-dependent expression of GADD45b through p38 activation. J Biol Chem. 2003;278(44):43001-7.
Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med. 2000;342(18):1350-8.
Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci. 2003;116(pt 2):217-24.
Euler-Taimor G, Heger J. The complex pattern of SMAD signaling in the cardiovascular system. Cardiovasc Res. 2006;69(1):15-25.
Chow JFC, Lee KF, Chan ST, Yeung WS. Quantification of transforming growth factor beta1 (TGFbeta1) mRNA expression in mouse preimplantation embryos and determination of TGFβ receptor (type I and type II) expression in mouse embryos and reproductive tract. Mol Hum Reprod. 2001;7(11):1047-56.
Simpson H, Robson SC, Bulmer JN, Barbar A, Lyall F. Transforming growth factor β expression in human placenta and placental bed during early pregnancy. Placenta. 2002;23(1):44-58.
Agarwal I, Karumanchi SA. Preeclampsia and the anti-angiogenic state. Pregnancy Hypertens. 2011;1(1):17-21.
Schumacher A, Brachwitz N, Sohr S, Engeland K, Langwisch S, Dolaptchieva M, et al. Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy. J Immunol. 2009;182(9):5488-97.
Kim SY, Lim JH, Park SY, Yang JH, Kim MY, Kim MH, et al. Transforming growth factor-beta 1 gene polymorphisms in Korean patients with preeclampsia. Am J Reprod Immunol. 2010;63(4):291-8.
Eller AG, Branch DW, Nelson L, Porter TF, Silver RM. Vascular endothelial growth factor-A gene polymorphisms in women with recurrent pregnancy loss. J Reprod Immunol. 2011;88(1):48-52.
Sun Y, Chen M, Mao B, Cheng X, Zhang X, Xu C. Association between vascular endothelial growth factor polymorphism and recurrentpregnancyloss: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2017;211:169-76.
Von Linsingen R, Bompeixe EP, Bicalho Mda M. A case-control study in IL6 and TGFB1 gene polymorphisms and recurrent spontaneous abortion in southern Brazilian patients. Am J Reprod Immunol. 2005;53(2):94-9.
Magdoud K, Granados V, Herbepin S, Messaoudi S, Hizem N, Bouafia WY, et al. Genetic variation in TGFB1 geneand risk of idiopathic recurrent pregnancy loss. Mol Hum Reprod. 2013;19(7):438-43.
Xu X, Du C, Li H, Du J, Yan X, Peng L, et al. Association of VEGF genetic polymorphisms with recurrent spontaneous abortion risk: a systematic review and meta-analysis. PLoS One. 2015;10(4):e0123696.
Rodriguez S, Gaunt TR, Day IN. Hardy-Weinberg equilibrium testing of biological ascertainment for mendelian randomization studies. Am J Epidemiol. 2009;169(4):505-14.
Petrie A, Bulman JS, Osborn JF. Further statistics in dentistry Part 8: systematic reviews and meta-analyses. Br Dent J. 2003;194:73-8.
Motsinger AA, Lee S, Mellick G, Ritchie MD. GPNN: power studies and applications of a neural network method for detecting gene-gene interactions in studies of human disease. BMC Bioinformatics. 2006;7:39.
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402-8.
Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine. 2000;12(8):1232-5.
Sa-Nguanraksa D, Chuangsuwanich T, Pongpruttipan T, Kummalue T, Rojananin S, Ratanawichhitrasin A, et al. Vascular endothelial growth factor 634G/C polymorphism is associated with increased breast cancer risk and aggressiveness. Mol Med Rep. 2013;8(4):1242-50.
Shahbazi M, Fryer AA, Pravica V, Brogan IJ, Ramsay HM, Hutchinson IV, et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol. 2002;13(1):260-4.
Papazoglou D, Galazios G, Papatheodorou K, Liberis V, Papanas N, Maltezos E, et al. Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancyloss. Fertil Steril. 2005;83(4):959-63.
Lee HH, Hong SH, Shin SJ, Ko JJ, Oh D, Kim NK. Association study of vascular endothelial growth factor polymorphisms with the risk of recurrent spontaneous abortion. Fertil Steril. 2010;93(4):1244-7.
Eller A, Branch DW, Nelson L, Silver R. The -634GC polymorphism in the regulatory 5′ untranslated region (5′ UTR) of the vascular endothelial growth factor (VEGF) gene is associated with unexplained recurrent pregnancy loss (RPL). Am J Obstet Gynecol. 2008;199(6):S81.
Li X, Shen L, Tan H. Polymorphisms and plasma level of transforming growth factor-Beta 1 and risk for preeclampsia: a systematic review. PLoS One. 2014;9(5):e97230.
Amani D, Dehaghani AS, Zolghadri J, Ravangard F, Niikawa N, Yoshiura K, et al. Lack of association between the TGF-beta1 gene polymorphisms and recurrent spontaneous abortion. J Reprod Immunol. 2005;68(1-2):91-103.
Marchenko ZhS, Lukina GV. Vascular endothelial growth factor role in the rheumatoid arthritis pathogenesis. Sci Pract Rheumatol. 2005;1:57-60.
Zhang H, Yee D. Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motility. Cancer Res. 2002;62(15):4369-75.
Qiang YW, Yao L, Tosato G, Rudikoff S. Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells. Blood. 2004;103(1):301-8.
Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008;30(2):214-26.
Appert-Collin A, Hubert P, Crémel G, Bennasroune A. Role of ErbB receptors in cancer cell migration and invasion. Front Pharmacol. 2015;6:283-92.
Ferrari G, Cook BD, Terushkin V, Pintucci G, Mignatti P. Transforming growth factor-beta 1 (tgf-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis. J Cell Physiol. 2009;219(2):449-58.
Kyriakis JM. Making the connection: coupling of stress-activated ERK/MAPK (extracellular-signal-regulated kinase/mitogen-activatedprotein kinase) core signaling modules to extracellular stimuli and biological responses. Biochem Soc Symp. 1998;64:29-48.
Ferrari G, Pintucci G, Seghezzi G, Hyman K, Galloway AC, Mignatti P. VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc Natl Acad Sci USA. 2006;103(46):17260-5.
West MJ, Stoneley M, Willis AE. Translational induction of the c-myconcogene via activation of the FRAP/TOR signaling pathway. Oncogene. 1998;17(6):769-80.
Poniatowski ŁA, Wojdasiewicz P, Gasik R, Szukiewicz D. Transforming growth factor Beta family: insight into the role ofgrowthfactors in regulation of fracture healing biology and potential clinical applications. Mediators Inflamm. 2015;2015:137823.
Choi HK, Choi BC, Lee SH, Kim JW, Cha KY, Baek KH. Expression of angiogenesis- and apoptosis-related genes in chorionic villi derived from recurrent pregnancy loss patients. Mol Reprod Dev. 2003;66(1):24-31.
Pang L, Wei Z, Li O, Huang R, Qin J, Chen H, et al. An increase in vascular endothelial growth factor (VEGF) and VEGF soluble receptor-1 (sFlt-1) are associated with early recurrent spontaneous abortion. PLoS One. 2013;8(9):e75759.
Yalcintepe SA, Silan F, Hacivelioglu SO, Uludag A, Cosar E, Ozdemir O. Fetal Vegf genotype is more important for abortion risk than mother genotype. Int J Mol Cell Med. 2014;3(2):88-94.
Morrish DW, Bhardwaj D, Paras MT. Transforming growth factor beta 1 inhibits placental differentiation and human chorionic gonadotropin and human placental lactogen secretion. Endocrinology. 1991;129(1):22-6.
Hocevar BA, Brown TL, Howe PH. TGF-b induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent Smad4-independent pathway. EMBO J. 1999;18(5):1345-56.
Yoo J, Ghiassi M, Jirmanova L, Balliet AG, Hoffman B, Fornace AJ, ET AL. Transforming growth factor-beta-induced apoptosis is mediated by Smad-dependent expression of GADD45b through p38 activation. J Biol Chem. 2003;278(44):43001-7.
Cao Y, Townsend CM, Ko T. Transforming growth factor-beta (TGF-beta) induces vascular endothelial growth factor (VEGF) and plasminogen activator inhibitor-1 (PAI-1) gene expression through Smad3 transcription factor. J Am Coll Surg. 2005;201(3):S17-S18.
Journal of Reproduction & Infertility
Volume 19, Issue 4
Autumn 2018
Pages 219-228